nodes	percent_of_prediction	percent_of_DWPC	metapath
Sodium lauryl sulfate—ALB—Abiraterone—prostate cancer	0.243	0.401	CbGbCtD
Sodium lauryl sulfate—ALB—Estrone—prostate cancer	0.176	0.29	CbGbCtD
Sodium lauryl sulfate—ALB—Estradiol—prostate cancer	0.101	0.166	CbGbCtD
Sodium lauryl sulfate—ALB—Prednisone—prostate cancer	0.0868	0.143	CbGbCtD
Sodium lauryl sulfate—Decamethonium—ACHE—prostate cancer	0.00207	0.71	CrCbGaD
Sodium lauryl sulfate—Ethanolamine Oleate—CYP2E1—prostate cancer	0.000846	0.29	CrCbGaD
Sodium lauryl sulfate—Decreased appetite—Mitoxantrone—prostate cancer	0.000149	0.000413	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Docetaxel—prostate cancer	0.000149	0.000413	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Etoposide—prostate cancer	0.000149	0.000412	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Epirubicin—prostate cancer	0.000148	0.00041	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Mitoxantrone—prostate cancer	0.000148	0.000409	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Goserelin—prostate cancer	0.000148	0.000409	CcSEcCtD
Sodium lauryl sulfate—Constipation—Mitoxantrone—prostate cancer	0.000147	0.000406	CcSEcCtD
Sodium lauryl sulfate—Rash—Goserelin—prostate cancer	0.000147	0.000405	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Goserelin—prostate cancer	0.000147	0.000405	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Conjugated Estrogens—prostate cancer	0.000147	0.000405	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Estradiol—prostate cancer	0.000147	0.000405	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Estradiol—prostate cancer	0.000146	0.000403	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Estradiol—prostate cancer	0.000146	0.000403	CcSEcCtD
Sodium lauryl sulfate—Headache—Goserelin—prostate cancer	0.000146	0.000403	CcSEcCtD
Sodium lauryl sulfate—Rash—Conjugated Estrogens—prostate cancer	0.000145	0.000401	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Conjugated Estrogens—prostate cancer	0.000145	0.000401	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Capecitabine—prostate cancer	0.000145	0.0004	CcSEcCtD
Sodium lauryl sulfate—Headache—Conjugated Estrogens—prostate cancer	0.000144	0.000399	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Etoposide—prostate cancer	0.000143	0.000395	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Docetaxel—prostate cancer	0.000143	0.000394	CcSEcCtD
Sodium lauryl sulfate—Infection—Etoposide—prostate cancer	0.000142	0.000392	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Epirubicin—prostate cancer	0.000142	0.000392	CcSEcCtD
Sodium lauryl sulfate—Blood creatinine increased—Doxorubicin—prostate cancer	0.000141	0.00039	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Epirubicin—prostate cancer	0.000141	0.000389	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000141	0.000388	CcSEcCtD
Sodium lauryl sulfate—Dehydration—Doxorubicin—prostate cancer	0.00014	0.000388	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Etoposide—prostate cancer	0.00014	0.000385	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Capecitabine—prostate cancer	0.000139	0.000384	CcSEcCtD
Sodium lauryl sulfate—Nausea—Goserelin—prostate cancer	0.000138	0.000382	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Etoposide—prostate cancer	0.000138	0.000382	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Capecitabine—prostate cancer	0.000138	0.000381	CcSEcCtD
Sodium lauryl sulfate—Hypokalaemia—Doxorubicin—prostate cancer	0.000137	0.000379	CcSEcCtD
Sodium lauryl sulfate—Nausea—Conjugated Estrogens—prostate cancer	0.000137	0.000378	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Mitoxantrone—prostate cancer	0.000137	0.000377	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Etoposide—prostate cancer	0.000136	0.000376	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Estradiol—prostate cancer	0.000136	0.000375	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Mitoxantrone—prostate cancer	0.000136	0.000375	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Mitoxantrone—prostate cancer	0.000136	0.000375	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Epirubicin—prostate cancer	0.000136	0.000374	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Etoposide—prostate cancer	0.000134	0.000369	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Capecitabine—prostate cancer	0.000133	0.000367	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Estradiol—prostate cancer	0.000132	0.000366	CcSEcCtD
Sodium lauryl sulfate—Abdominal distension—Doxorubicin—prostate cancer	0.000131	0.000363	CcSEcCtD
Sodium lauryl sulfate—Syncope—Docetaxel—prostate cancer	0.000131	0.000361	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Estradiol—prostate cancer	0.000131	0.000361	CcSEcCtD
Sodium lauryl sulfate—Dysphagia—Doxorubicin—prostate cancer	0.00013	0.00036	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Prednisone—prostate cancer	0.000129	0.000356	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Docetaxel—prostate cancer	0.000129	0.000355	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Etoposide—prostate cancer	0.000128	0.000355	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Docetaxel—prostate cancer	0.000128	0.000353	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Etoposide—prostate cancer	0.000127	0.000352	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Mitoxantrone—prostate cancer	0.000127	0.00035	CcSEcCtD
Sodium lauryl sulfate—Syncope—Capecitabine—prostate cancer	0.000126	0.000349	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Estradiol—prostate cancer	0.000126	0.000349	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Docetaxel—prostate cancer	0.000126	0.000348	CcSEcCtD
Sodium lauryl sulfate—Bronchitis—Doxorubicin—prostate cancer	0.000125	0.000346	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Capecitabine—prostate cancer	0.000125	0.000344	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Etoposide—prostate cancer	0.000124	0.000343	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Docetaxel—prostate cancer	0.000124	0.000342	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Capecitabine—prostate cancer	0.000124	0.000342	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Epirubicin—prostate cancer	0.000124	0.000341	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Mitoxantrone—prostate cancer	0.000123	0.000341	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Etoposide—prostate cancer	0.000123	0.00034	CcSEcCtD
Sodium lauryl sulfate—Constipation—Etoposide—prostate cancer	0.000122	0.000338	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Estradiol—prostate cancer	0.000122	0.000337	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Capecitabine—prostate cancer	0.00012	0.000331	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Capecitabine—prostate cancer	0.00012	0.00033	CcSEcCtD
Sodium lauryl sulfate—Oedema—Docetaxel—prostate cancer	0.000119	0.000328	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Docetaxel—prostate cancer	0.000119	0.000328	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Prednisone—prostate cancer	0.000118	0.000327	CcSEcCtD
Sodium lauryl sulfate—Infection—Docetaxel—prostate cancer	0.000118	0.000326	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Mitoxantrone—prostate cancer	0.000118	0.000325	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Estradiol—prostate cancer	0.000117	0.000324	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Etoposide—prostate cancer	0.000117	0.000323	CcSEcCtD
Sodium lauryl sulfate—Shock—Docetaxel—prostate cancer	0.000117	0.000323	CcSEcCtD
Sodium lauryl sulfate—Rash—Estradiol—prostate cancer	0.000116	0.000321	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Estradiol—prostate cancer	0.000116	0.000321	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Docetaxel—prostate cancer	0.000116	0.00032	CcSEcCtD
Sodium lauryl sulfate—Headache—Estradiol—prostate cancer	0.000116	0.000319	CcSEcCtD
Sodium lauryl sulfate—Oedema—Capecitabine—prostate cancer	0.000115	0.000318	CcSEcCtD
Sodium lauryl sulfate—Renal failure—Doxorubicin—prostate cancer	0.000114	0.000316	CcSEcCtD
Sodium lauryl sulfate—Infection—Capecitabine—prostate cancer	0.000114	0.000316	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Etoposide—prostate cancer	0.000114	0.000314	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Docetaxel—prostate cancer	0.000113	0.000313	CcSEcCtD
Sodium lauryl sulfate—Shock—Capecitabine—prostate cancer	0.000113	0.000313	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Etoposide—prostate cancer	0.000113	0.000312	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Etoposide—prostate cancer	0.000113	0.000312	CcSEcCtD
Sodium lauryl sulfate—Syncope—Prednisone—prostate cancer	0.000113	0.000311	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Capecitabine—prostate cancer	0.000112	0.00031	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Epirubicin—prostate cancer	0.000112	0.00031	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Capecitabine—prostate cancer	0.000111	0.000307	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Docetaxel—prostate cancer	0.000111	0.000307	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Prednisone—prostate cancer	0.00011	0.000305	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Capecitabine—prostate cancer	0.00011	0.000303	CcSEcCtD
Sodium lauryl sulfate—Nausea—Estradiol—prostate cancer	0.00011	0.000303	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Mitoxantrone—prostate cancer	0.000109	0.000302	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Prednisone—prostate cancer	0.000109	0.0003	CcSEcCtD
Sodium lauryl sulfate—Rash—Mitoxantrone—prostate cancer	0.000108	0.000299	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Mitoxantrone—prostate cancer	0.000108	0.000299	CcSEcCtD
Sodium lauryl sulfate—Headache—Mitoxantrone—prostate cancer	0.000108	0.000297	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Capecitabine—prostate cancer	0.000108	0.000297	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Docetaxel—prostate cancer	0.000107	0.000295	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Prednisone—prostate cancer	0.000107	0.000294	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Docetaxel—prostate cancer	0.000106	0.000293	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Etoposide—prostate cancer	0.000105	0.000291	CcSEcCtD
Sodium lauryl sulfate—Hypoaesthesia—Doxorubicin—prostate cancer	0.000104	0.000287	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Capecitabine—prostate cancer	0.000103	0.000285	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Docetaxel—prostate cancer	0.000103	0.000285	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Etoposide—prostate cancer	0.000103	0.000283	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Capecitabine—prostate cancer	0.000103	0.000283	CcSEcCtD
Sodium lauryl sulfate—Oedema—Prednisone—prostate cancer	0.000102	0.000283	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Prednisone—prostate cancer	0.000102	0.000283	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Docetaxel—prostate cancer	0.000102	0.000283	CcSEcCtD
Sodium lauryl sulfate—Nausea—Mitoxantrone—prostate cancer	0.000102	0.000282	CcSEcCtD
Sodium lauryl sulfate—Infection—Prednisone—prostate cancer	0.000102	0.000281	CcSEcCtD
Sodium lauryl sulfate—Constipation—Docetaxel—prostate cancer	0.000102	0.000281	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GRHL1—prostate cancer	0.000101	0.00356	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Etoposide—prostate cancer	0.000101	0.000279	CcSEcCtD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—SERPINE1—prostate cancer	0.000101	0.00355	CbGpPWpGaD
Sodium lauryl sulfate—Shock—Prednisone—prostate cancer	0.000101	0.000278	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Epirubicin—prostate cancer	0.000101	0.000278	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Prednisone—prostate cancer	0.0001	0.000276	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Capecitabine—prostate cancer	0.0001	0.000276	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Capecitabine—prostate cancer	9.92e-05	0.000274	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Prednisone—prostate cancer	9.91e-05	0.000274	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—ITGB3—prostate cancer	9.87e-05	0.00346	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—ICAM1—prostate cancer	9.85e-05	0.00346	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Capecitabine—prostate cancer	9.84e-05	0.000272	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—CLU—prostate cancer	9.81e-05	0.00344	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Etoposide—prostate cancer	9.78e-05	0.00027	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Prednisone—prostate cancer	9.77e-05	0.00027	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Docetaxel—prostate cancer	9.72e-05	0.000268	CcSEcCtD
Sodium lauryl sulfate—Flatulence—Epirubicin—prostate cancer	9.68e-05	0.000267	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	9.67e-05	0.00339	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC7A1—prostate cancer	9.64e-05	0.00338	CbGpPWpGaD
Sodium lauryl sulfate—Dysgeusia—Epirubicin—prostate cancer	9.62e-05	0.000266	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Etoposide—prostate cancer	9.46e-05	0.000261	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Capecitabine—prostate cancer	9.41e-05	0.00026	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Docetaxel—prostate cancer	9.39e-05	0.000259	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Docetaxel—prostate cancer	9.39e-05	0.000259	CcSEcCtD
Sodium lauryl sulfate—Arrhythmia—Doxorubicin—prostate cancer	9.33e-05	0.000258	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Epirubicin—prostate cancer	9.26e-05	0.000256	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Prednisone—prostate cancer	9.2e-05	0.000254	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Capecitabine—prostate cancer	9.14e-05	0.000252	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Capecitabine—prostate cancer	9.1e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Capecitabine—prostate cancer	9.1e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Etoposide—prostate cancer	9.09e-05	0.000251	CcSEcCtD
Sodium lauryl sulfate—Rash—Etoposide—prostate cancer	9.02e-05	0.000249	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Etoposide—prostate cancer	9.01e-05	0.000249	CcSEcCtD
Sodium lauryl sulfate—Headache—Etoposide—prostate cancer	8.96e-05	0.000247	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—INS—prostate cancer	8.96e-05	0.00314	CbGpPWpGaD
Sodium lauryl sulfate—Flatulence—Doxorubicin—prostate cancer	8.96e-05	0.000247	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—MTHFR—prostate cancer	8.95e-05	0.00314	CbGpPWpGaD
Sodium lauryl sulfate—Decreased appetite—Prednisone—prostate cancer	8.91e-05	0.000246	CcSEcCtD
Sodium lauryl sulfate—Dysgeusia—Doxorubicin—prostate cancer	8.9e-05	0.000246	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—MBTPS1—prostate cancer	8.87e-05	0.00311	CbGpPWpGaD
Sodium lauryl sulfate—Fatigue—Prednisone—prostate cancer	8.84e-05	0.000244	CcSEcCtD
Sodium lauryl sulfate—Syncope—Epirubicin—prostate cancer	8.81e-05	0.000243	CcSEcCtD
Sodium lauryl sulfate—Constipation—Prednisone—prostate cancer	8.76e-05	0.000242	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Docetaxel—prostate cancer	8.76e-05	0.000242	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Epirubicin—prostate cancer	8.68e-05	0.00024	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Epirubicin—prostate cancer	8.63e-05	0.000238	CcSEcCtD
Sodium lauryl sulfate—Vision blurred—Doxorubicin—prostate cancer	8.56e-05	0.000237	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—GNG5—prostate cancer	8.54e-05	0.003	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Docetaxel—prostate cancer	8.53e-05	0.000235	CcSEcCtD
Sodium lauryl sulfate—Convulsion—Epirubicin—prostate cancer	8.51e-05	0.000235	CcSEcCtD
Sodium lauryl sulfate—Nausea—Etoposide—prostate cancer	8.49e-05	0.000235	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Capecitabine—prostate cancer	8.48e-05	0.000234	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—STX4—prostate cancer	8.44e-05	0.00296	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—RAD51B—prostate cancer	8.44e-05	0.00296	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Docetaxel—prostate cancer	8.41e-05	0.000232	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SRD5A2—prostate cancer	8.4e-05	0.00295	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—DEGS1—prostate cancer	8.4e-05	0.00295	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—AMACR—prostate cancer	8.4e-05	0.00295	CbGpPWpGaD
Sodium lauryl sulfate—Gastrointestinal pain—Prednisone—prostate cancer	8.38e-05	0.000231	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Epirubicin—prostate cancer	8.36e-05	0.000231	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Epirubicin—prostate cancer	8.33e-05	0.00023	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Capecitabine—prostate cancer	8.26e-05	0.000228	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—SERPINE1—prostate cancer	8.23e-05	0.00289	CbGpPWpGaD
Sodium lauryl sulfate—Syncope—Doxorubicin—prostate cancer	8.15e-05	0.000225	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Prednisone—prostate cancer	8.14e-05	0.000225	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Capecitabine—prostate cancer	8.14e-05	0.000225	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Docetaxel—prostate cancer	8.13e-05	0.000225	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Prednisone—prostate cancer	8.1e-05	0.000224	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Prednisone—prostate cancer	8.1e-05	0.000224	CcSEcCtD
Sodium lauryl sulfate—Palpitations—Doxorubicin—prostate cancer	8.03e-05	0.000222	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—EGF—prostate cancer	8.02e-05	0.00281	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD17B1—prostate cancer	8.02e-05	0.00281	CbGpPWpGaD
Sodium lauryl sulfate—Anaphylactic shock—Epirubicin—prostate cancer	8.02e-05	0.000221	CcSEcCtD
Sodium lauryl sulfate—Oedema—Epirubicin—prostate cancer	8.02e-05	0.000221	CcSEcCtD
Sodium lauryl sulfate—Loss of consciousness—Doxorubicin—prostate cancer	7.99e-05	0.000221	CcSEcCtD
Sodium lauryl sulfate—Infection—Epirubicin—prostate cancer	7.96e-05	0.00022	CcSEcCtD
Sodium lauryl sulfate—Shock—Epirubicin—prostate cancer	7.89e-05	0.000218	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	7.88e-05	0.00277	CbGpPWpGaD
Sodium lauryl sulfate—Convulsion—Doxorubicin—prostate cancer	7.87e-05	0.000217	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Capecitabine—prostate cancer	7.87e-05	0.000217	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Docetaxel—prostate cancer	7.86e-05	0.000217	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—ICAM1—prostate cancer	7.82e-05	0.00275	CbGpPWpGaD
Sodium lauryl sulfate—Tachycardia—Epirubicin—prostate cancer	7.82e-05	0.000216	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Epirubicin—prostate cancer	7.75e-05	0.000214	CcSEcCtD
Sodium lauryl sulfate—Chest pain—Doxorubicin—prostate cancer	7.74e-05	0.000214	CcSEcCtD
Sodium lauryl sulfate—Anxiety—Doxorubicin—prostate cancer	7.71e-05	0.000213	CcSEcCtD
Sodium lauryl sulfate—Anorexia—Epirubicin—prostate cancer	7.64e-05	0.000211	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—EGF—prostate cancer	7.64e-05	0.00268	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC39A1—prostate cancer	7.62e-05	0.00268	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Capecitabine—prostate cancer	7.61e-05	0.00021	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—F9—prostate cancer	7.6e-05	0.00267	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Docetaxel—prostate cancer	7.56e-05	0.000209	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Prednisone—prostate cancer	7.55e-05	0.000209	CcSEcCtD
Sodium lauryl sulfate—Rash—Docetaxel—prostate cancer	7.49e-05	0.000207	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Epirubicin—prostate cancer	7.49e-05	0.000207	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Docetaxel—prostate cancer	7.49e-05	0.000207	CcSEcCtD
Sodium lauryl sulfate—Headache—Docetaxel—prostate cancer	7.45e-05	0.000206	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—IGF1—prostate cancer	7.43e-05	0.00261	CbGpPWpGaD
Sodium lauryl sulfate—Oedema—Doxorubicin—prostate cancer	7.42e-05	0.000205	CcSEcCtD
Sodium lauryl sulfate—Anaphylactic shock—Doxorubicin—prostate cancer	7.42e-05	0.000205	CcSEcCtD
Sodium lauryl sulfate—Infection—Doxorubicin—prostate cancer	7.37e-05	0.000203	CcSEcCtD
Sodium lauryl sulfate—Asthenia—Prednisone—prostate cancer	7.35e-05	0.000203	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Capecitabine—prostate cancer	7.32e-05	0.000202	CcSEcCtD
Sodium lauryl sulfate—Shock—Doxorubicin—prostate cancer	7.3e-05	0.000202	CcSEcCtD
Sodium lauryl sulfate—Rash—Capecitabine—prostate cancer	7.25e-05	0.0002	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Prednisone—prostate cancer	7.25e-05	0.0002	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Capecitabine—prostate cancer	7.25e-05	0.0002	CcSEcCtD
Sodium lauryl sulfate—Tachycardia—Doxorubicin—prostate cancer	7.24e-05	0.0002	CcSEcCtD
Sodium lauryl sulfate—Headache—Capecitabine—prostate cancer	7.21e-05	0.000199	CcSEcCtD
Sodium lauryl sulfate—Paraesthesia—Epirubicin—prostate cancer	7.2e-05	0.000199	CcSEcCtD
Sodium lauryl sulfate—Hyperhidrosis—Doxorubicin—prostate cancer	7.17e-05	0.000198	CcSEcCtD
Sodium lauryl sulfate—Dyspnoea—Epirubicin—prostate cancer	7.15e-05	0.000197	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HPGD—prostate cancer	7.15e-05	0.00251	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—INS—prostate cancer	7.12e-05	0.0025	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—THBS1—prostate cancer	7.09e-05	0.00249	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—prostate cancer	7.08e-05	0.00248	CbGpPWpGaD
Sodium lauryl sulfate—Anorexia—Doxorubicin—prostate cancer	7.07e-05	0.000195	CcSEcCtD
Sodium lauryl sulfate—Nausea—Docetaxel—prostate cancer	7.06e-05	0.000195	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—SERPINE1—prostate cancer	7.05e-05	0.00248	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Prednisone—prostate cancer	7.01e-05	0.000194	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Epirubicin—prostate cancer	6.97e-05	0.000192	CcSEcCtD
Sodium lauryl sulfate—Hypotension—Doxorubicin—prostate cancer	6.93e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Epirubicin—prostate cancer	6.91e-05	0.000191	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCZ—prostate cancer	6.86e-05	0.00241	CbGpPWpGaD
Sodium lauryl sulfate—Constipation—Epirubicin—prostate cancer	6.85e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Nausea—Capecitabine—prostate cancer	6.83e-05	0.000189	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Prednisone—prostate cancer	6.78e-05	0.000187	CcSEcCtD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—prostate cancer	6.72e-05	0.00236	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—TNFRSF21—prostate cancer	6.72e-05	0.00236	CbGpPWpGaD
Sodium lauryl sulfate—Paraesthesia—Doxorubicin—prostate cancer	6.66e-05	0.000184	CcSEcCtD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL2—prostate cancer	6.66e-05	0.00234	CbGpPWpGaD
Sodium lauryl sulfate—Dyspnoea—Doxorubicin—prostate cancer	6.61e-05	0.000183	CcSEcCtD
Sodium lauryl sulfate—Gastrointestinal pain—Epirubicin—prostate cancer	6.55e-05	0.000181	CcSEcCtD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—SERPINE1—prostate cancer	6.54e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP7B1—prostate cancer	6.54e-05	0.00229	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Prednisone—prostate cancer	6.52e-05	0.00018	CcSEcCtD
Sodium lauryl sulfate—Rash—Prednisone—prostate cancer	6.46e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Prednisone—prostate cancer	6.46e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Decreased appetite—Doxorubicin—prostate cancer	6.45e-05	0.000178	CcSEcCtD
Sodium lauryl sulfate—Headache—Prednisone—prostate cancer	6.42e-05	0.000177	CcSEcCtD
Sodium lauryl sulfate—Fatigue—Doxorubicin—prostate cancer	6.39e-05	0.000177	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SRD5A1—prostate cancer	6.37e-05	0.00224	CbGpPWpGaD
Sodium lauryl sulfate—Urticaria—Epirubicin—prostate cancer	6.37e-05	0.000176	CcSEcCtD
Sodium lauryl sulfate—Constipation—Doxorubicin—prostate cancer	6.34e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Epirubicin—prostate cancer	6.34e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Epirubicin—prostate cancer	6.34e-05	0.000175	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CYP7B1—prostate cancer	6.21e-05	0.00218	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Prednisone—prostate cancer	6.09e-05	0.000168	CcSEcCtD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD17B3—prostate cancer	6.08e-05	0.00213	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ACSL4—prostate cancer	6.08e-05	0.00213	CbGpPWpGaD
Sodium lauryl sulfate—Gastrointestinal pain—Doxorubicin—prostate cancer	6.07e-05	0.000167	CcSEcCtD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC12A2—prostate cancer	6.06e-05	0.00213	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC26A4—prostate cancer	6.06e-05	0.00213	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGA6—prostate cancer	5.95e-05	0.00209	CbGpPWpGaD
Sodium lauryl sulfate—Hypersensitivity—Epirubicin—prostate cancer	5.91e-05	0.000163	CcSEcCtD
Sodium lauryl sulfate—Urticaria—Doxorubicin—prostate cancer	5.89e-05	0.000163	CcSEcCtD
Sodium lauryl sulfate—Abdominal pain—Doxorubicin—prostate cancer	5.86e-05	0.000162	CcSEcCtD
Sodium lauryl sulfate—Body temperature increased—Doxorubicin—prostate cancer	5.86e-05	0.000162	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PRKCQ—prostate cancer	5.84e-05	0.00205	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Epirubicin—prostate cancer	5.75e-05	0.000159	CcSEcCtD
Sodium lauryl sulfate—ALB—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	5.75e-05	0.00202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—PTGS2—prostate cancer	5.71e-05	0.002	CbGpPWpGaD
Sodium lauryl sulfate—Pruritus—Epirubicin—prostate cancer	5.67e-05	0.000157	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—CD9—prostate cancer	5.59e-05	0.00196	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HAO1—prostate cancer	5.54e-05	0.00194	CbGpPWpGaD
Sodium lauryl sulfate—Diarrhoea—Epirubicin—prostate cancer	5.48e-05	0.000151	CcSEcCtD
Sodium lauryl sulfate—Hypersensitivity—Doxorubicin—prostate cancer	5.46e-05	0.000151	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VAV3—prostate cancer	5.35e-05	0.00188	CbGpPWpGaD
Sodium lauryl sulfate—Asthenia—Doxorubicin—prostate cancer	5.32e-05	0.000147	CcSEcCtD
Sodium lauryl sulfate—Dizziness—Epirubicin—prostate cancer	5.3e-05	0.000146	CcSEcCtD
Sodium lauryl sulfate—Pruritus—Doxorubicin—prostate cancer	5.25e-05	0.000145	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ITPR1—prostate cancer	5.19e-05	0.00182	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD3B1—prostate cancer	5.17e-05	0.00181	CbGpPWpGaD
Sodium lauryl sulfate—Vomiting—Epirubicin—prostate cancer	5.1e-05	0.000141	CcSEcCtD
Sodium lauryl sulfate—Diarrhoea—Doxorubicin—prostate cancer	5.07e-05	0.00014	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—CLU—prostate cancer	5.06e-05	0.00178	CbGpPWpGaD
Sodium lauryl sulfate—Rash—Epirubicin—prostate cancer	5.05e-05	0.00014	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Epirubicin—prostate cancer	5.05e-05	0.000139	CcSEcCtD
Sodium lauryl sulfate—Headache—Epirubicin—prostate cancer	5.02e-05	0.000139	CcSEcCtD
Sodium lauryl sulfate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—prostate cancer	4.99e-05	0.00175	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—TBXAS1—prostate cancer	4.95e-05	0.00174	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC22A3—prostate cancer	4.91e-05	0.00172	CbGpPWpGaD
Sodium lauryl sulfate—Dizziness—Doxorubicin—prostate cancer	4.9e-05	0.000135	CcSEcCtD
Sodium lauryl sulfate—ALB—Platelet degranulation—VEGFA—prostate cancer	4.85e-05	0.0017	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Vitamin B12 Metabolism—IL6—prostate cancer	4.81e-05	0.00169	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ABCG5—prostate cancer	4.77e-05	0.00167	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Epirubicin—prostate cancer	4.76e-05	0.000131	CcSEcCtD
Sodium lauryl sulfate—Vomiting—Doxorubicin—prostate cancer	4.72e-05	0.00013	CcSEcCtD
Sodium lauryl sulfate—Rash—Doxorubicin—prostate cancer	4.68e-05	0.000129	CcSEcCtD
Sodium lauryl sulfate—Dermatitis—Doxorubicin—prostate cancer	4.67e-05	0.000129	CcSEcCtD
Sodium lauryl sulfate—Headache—Doxorubicin—prostate cancer	4.65e-05	0.000128	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—GRB7—prostate cancer	4.63e-05	0.00162	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—prostate cancer	4.62e-05	0.00162	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HSD3B2—prostate cancer	4.6e-05	0.00162	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—ITGB3—prostate cancer	4.59e-05	0.00161	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—ABCG5—prostate cancer	4.53e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TST—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CSAD—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GRHL1—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PSAT1—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CBR1—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ADI1—prostate cancer	4.52e-05	0.00159	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet degranulation—TGFB1—prostate cancer	4.45e-05	0.00156	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—LRP2—prostate cancer	4.41e-05	0.00155	CbGpPWpGaD
Sodium lauryl sulfate—Nausea—Doxorubicin—prostate cancer	4.41e-05	0.000122	CcSEcCtD
Sodium lauryl sulfate—ALB—Hemostasis—GNG5—prostate cancer	4.4e-05	0.00154	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—P4HB—prostate cancer	4.33e-05	0.00152	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—TP53—prostate cancer	4.28e-05	0.0015	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—prostate cancer	4.24e-05	0.00149	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UGT2B17—prostate cancer	4.2e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GRHPR—prostate cancer	4.2e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UGT2B15—prostate cancer	4.2e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CKMT2—prostate cancer	4.2e-05	0.00147	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—SULT2A1—prostate cancer	4.1e-05	0.00144	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—MED12—prostate cancer	4.04e-05	0.00142	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4e-05	0.00141	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTM3—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SULT2B1—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AOX1—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PGAM2—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—RFK—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NAGLU—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MBTPS1—prostate cancer	3.95e-05	0.00139	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Folate Metabolism—IL6—prostate cancer	3.91e-05	0.00137	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA3—prostate cancer	3.86e-05	0.00135	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—GNG5—prostate cancer	3.81e-05	0.00134	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKACB—prostate cancer	3.75e-05	0.00132	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AMACR—prostate cancer	3.74e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP3A43—prostate cancer	3.74e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—DEGS1—prostate cancer	3.74e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SRD5A2—prostate cancer	3.74e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NAT1—prostate cancer	3.74e-05	0.00131	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—HPGDS—prostate cancer	3.68e-05	0.00129	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP2C19—prostate cancer	3.66e-05	0.00128	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—THBS1—prostate cancer	3.66e-05	0.00128	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CG—prostate cancer	3.6e-05	0.00126	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD17B1—prostate cancer	3.57e-05	0.00125	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—ACHE—prostate cancer	3.57e-05	0.00125	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—EGF—prostate cancer	3.56e-05	0.00125	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCZ—prostate cancer	3.54e-05	0.00124	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	3.43e-05	0.0012	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	3.42e-05	0.0012	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	3.38e-05	0.00119	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IGF1—prostate cancer	3.29e-05	0.00116	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PRKACB—prostate cancer	3.25e-05	0.00114	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	3.22e-05	0.00113	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—B4GALT4—prostate cancer	3.18e-05	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HPGD—prostate cancer	3.18e-05	0.00112	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CD—prostate cancer	3.16e-05	0.00111	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SERPINE1—prostate cancer	3.13e-05	0.0011	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Selenium Micronutrient Network—IL6—prostate cancer	3.11e-05	0.00109	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.06e-05	0.00107	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PRKCQ—prostate cancer	3.01e-05	0.00106	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TNFRSF21—prostate cancer	2.99e-05	0.00105	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAUR—prostate cancer	2.97e-05	0.00104	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—SLC5A5—prostate cancer	2.92e-05	0.00103	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP7B1—prostate cancer	2.91e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTAP—prostate cancer	2.91e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—JAK2—prostate cancer	2.9e-05	0.00102	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	2.84e-05	0.000998	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SULT1E1—prostate cancer	2.84e-05	0.000995	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SRD5A1—prostate cancer	2.84e-05	0.000995	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VAV3—prostate cancer	2.76e-05	0.000968	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CB—prostate cancer	2.76e-05	0.000968	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	2.76e-05	0.000967	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	2.71e-05	0.000952	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD17B3—prostate cancer	2.71e-05	0.00095	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ACSL4—prostate cancer	2.71e-05	0.00095	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITPR1—prostate cancer	2.67e-05	0.000939	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	2.67e-05	0.000939	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PHGDH—prostate cancer	2.59e-05	0.00091	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ARG2—prostate cancer	2.59e-05	0.00091	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UMPS—prostate cancer	2.59e-05	0.00091	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	2.58e-05	0.000906	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—NCOA1—prostate cancer	2.58e-05	0.000906	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LDHB—prostate cancer	2.54e-05	0.000893	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—IL2—prostate cancer	2.53e-05	0.000889	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP3A5—prostate cancer	2.5e-05	0.000876	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—RXRA—prostate cancer	2.45e-05	0.000861	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PDHA1—prostate cancer	2.41e-05	0.000846	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA3—prostate cancer	2.41e-05	0.000846	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—UCP3—prostate cancer	2.41e-05	0.000846	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TCN2—prostate cancer	2.41e-05	0.000846	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—ITGB3—prostate cancer	2.37e-05	0.000831	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC22A3—prostate cancer	2.3e-05	0.000807	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD3B1—prostate cancer	2.3e-05	0.000807	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—LPL—prostate cancer	2.23e-05	0.000783	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—SRC—prostate cancer	2.21e-05	0.000775	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TBXAS1—prostate cancer	2.21e-05	0.000774	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA4—prostate cancer	2.21e-05	0.000774	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	2.16e-05	0.000757	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—VEGFA—prostate cancer	2.15e-05	0.000755	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA2—prostate cancer	2.15e-05	0.000754	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SULT1A1—prostate cancer	2.12e-05	0.000745	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ABCG5—prostate cancer	2.12e-05	0.000745	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PLAU—prostate cancer	2.08e-05	0.000732	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTA1—prostate cancer	2.07e-05	0.000728	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTO1—prostate cancer	2.05e-05	0.00072	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HSD3B2—prostate cancer	2.05e-05	0.00072	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NAT2—prostate cancer	2.05e-05	0.00072	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CAV1—prostate cancer	2.04e-05	0.000715	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—TGFB1—prostate cancer	1.98e-05	0.000693	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	1.97e-05	0.000692	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PLCB2—prostate cancer	1.97e-05	0.00069	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LRP2—prostate cancer	1.97e-05	0.00069	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2C18—prostate cancer	1.97e-05	0.00069	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—P4HB—prostate cancer	1.93e-05	0.000677	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC22A1—prostate cancer	1.88e-05	0.000658	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—PPARA—prostate cancer	1.87e-05	0.000658	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CG—prostate cancer	1.85e-05	0.000651	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	1.85e-05	0.000651	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—EGF—prostate cancer	1.83e-05	0.000643	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SULT2A1—prostate cancer	1.83e-05	0.000641	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MED12—prostate cancer	1.8e-05	0.000631	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GNG5—prostate cancer	1.78e-05	0.000626	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—CREBBP—prostate cancer	1.72e-05	0.000604	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA3—prostate cancer	1.72e-05	0.000603	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IGF1—prostate cancer	1.7e-05	0.000596	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	1.69e-05	0.000593	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—PIK3CA—prostate cancer	1.68e-05	0.00059	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—HPGDS—prostate cancer	1.64e-05	0.000575	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CD—prostate cancer	1.63e-05	0.000572	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2C19—prostate cancer	1.63e-05	0.000572	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SERPINE1—prostate cancer	1.61e-05	0.000566	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ACHE—prostate cancer	1.59e-05	0.000558	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTT1—prostate cancer	1.59e-05	0.000558	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2A6—prostate cancer	1.57e-05	0.000552	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	1.57e-05	0.000549	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—NOS3—prostate cancer	1.54e-05	0.00054	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKR1C3—prostate cancer	1.53e-05	0.000537	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PRKACB—prostate cancer	1.52e-05	0.000534	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP17A1—prostate cancer	1.51e-05	0.000528	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—JAK2—prostate cancer	1.5e-05	0.000525	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.49e-05	0.000522	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	1.48e-05	0.000521	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA2—prostate cancer	1.43e-05	0.000503	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CB—prostate cancer	1.42e-05	0.000499	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Platelet activation, signaling and aggregation—AKT1—prostate cancer	1.37e-05	0.000482	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—SLC5A5—prostate cancer	1.37e-05	0.00048	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP2E1—prostate cancer	1.34e-05	0.000469	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NQO1—prostate cancer	1.32e-05	0.000464	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—IL2—prostate cancer	1.31e-05	0.000458	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TH—prostate cancer	1.3e-05	0.000457	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	1.29e-05	0.000454	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP3A4—prostate cancer	1.29e-05	0.000452	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	1.28e-05	0.00045	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP1B1—prostate cancer	1.27e-05	0.000445	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GGT1—prostate cancer	1.23e-05	0.000431	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NCOA1—prostate cancer	1.21e-05	0.000424	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP19A1—prostate cancer	1.19e-05	0.000418	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—EP300—prostate cancer	1.17e-05	0.000411	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—RXRA—prostate cancer	1.15e-05	0.000403	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—SRC—prostate cancer	1.14e-05	0.0004	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.12e-05	0.000392	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—VEGFA—prostate cancer	1.11e-05	0.000389	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—COMT—prostate cancer	1.11e-05	0.000389	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTP1—prostate cancer	1.1e-05	0.000387	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ITPR1—prostate cancer	1.08e-05	0.000381	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.07e-05	0.000374	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—TYMS—prostate cancer	1.02e-05	0.00036	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TGFB1—prostate cancer	1.02e-05	0.000357	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—GSTM1—prostate cancer	1.01e-05	0.000355	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—LPL—prostate cancer	9.94e-06	0.000349	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CYP1A1—prostate cancer	9.6e-06	0.000337	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—ERCC2—prostate cancer	9.52e-06	0.000334	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—KRAS—prostate cancer	9.43e-06	0.000331	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—MTHFR—prostate cancer	8.95e-06	0.000314	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PPARA—prostate cancer	8.78e-06	0.000308	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—PIK3CA—prostate cancer	8.66e-06	0.000304	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—TP53—prostate cancer	8.38e-06	0.000294	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CAV1—prostate cancer	8.26e-06	0.00029	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	7.89e-06	0.000277	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CG—prostate cancer	7.52e-06	0.000264	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—INS—prostate cancer	7.12e-06	0.00025	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Hemostasis—AKT1—prostate cancer	7.08e-06	0.000248	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—CREBBP—prostate cancer	6.97e-06	0.000245	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CD—prostate cancer	6.61e-06	0.000232	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—NOS3—prostate cancer	6.24e-06	0.000219	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CB—prostate cancer	5.76e-06	0.000202	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTGS2—prostate cancer	5.71e-06	0.0002	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PTEN—prostate cancer	4.98e-06	0.000175	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—EP300—prostate cancer	4.75e-06	0.000167	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—PIK3CA—prostate cancer	3.51e-06	0.000123	CbGpPWpGaD
Sodium lauryl sulfate—ALB—Metabolism—AKT1—prostate cancer	2.87e-06	0.000101	CbGpPWpGaD
